Prabhat Chemipharma Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
as on 22-12-2024
- Paid Up Capital ₹ 1.50 M
as on 22-12-2024
- Company Age 20 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Revenue -20.13%
(FY 2022)
- Profit -24.50%
(FY 2022)
- Ebitda -22.95%
(FY 2022)
- Net Worth 14.96%
(FY 2022)
- Total Assets 15.69%
(FY 2022)
About Prabhat Chemipharma
The Corporate was formerly known as Prabhat Chemipharam Private Limited. The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 1.50 M, as per Ministry of Corporate Affairs (MCA) records.
Paresh Savani and Dineshbhai Savani serve as directors at the Company.
- CIN/LLPIN
U24100MH2004PTC084703
- Company No.
084703
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Sep 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Prabhat Chemipharma Private Limited offer?
Prabhat Chemipharma Private Limited offers a wide range of products and services, including Chemical Reagents & Catalysts, Potassium Salts, Industrial Chemicals & Supplies, Industrial Acid, Ammonium Compound, Bromine Compound, Organic Acid, Disinfectant Chemicals, Organic Compounds, 1 4-Dibromobenzene.
Who are the key members and board of directors at Prabhat Chemipharma?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Paresh Savani  | Director | 14-Apr-2011 | Current |
| Dineshbhai Savani | Director | 04-Feb-2015 | Current |
Financial Performance of Prabhat Chemipharma.
Prabhat Chemipharma Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 20.13% decrease. The company also saw a substantial fall in profitability, with a 24.5% decrease in profit. The company's net worth Soared by an impressive increase of 14.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prabhat Chemipharma?
In 2021, Prabhat Chemipharma had a promoter holding of 25.00% and a public holding of 75.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Prabhat Chemipharma?
Unlock and access historical data on people associated with Prabhat Chemipharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prabhat Chemipharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prabhat Chemipharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
